Thursday October 19th, 2017

          

 

10:00 - 12:30

Professional group meetings:

( For program click the line)

CF Center physicians

CF Nurses

CF Dieticians

CF Physiotherapists  

CF Psychologists and social workers

12:30 - 13:30

Light Lunch

Congress opening and greetings

Session A: " Clinical Challenges"

(Session conducted in Hebrew)

Chairs: Dr. Malena Cohen-Cymberknoh, MD, and Dr. Galit Livnat, MD

13:30 - 13:35

Welcome and Introduction

 

13:35 - 13:50

 

Continuous vs. alternating inhaled antibiotic therapy in CF

Michal Gur, MD, CF Center  Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa

 

13:50 - 14:05

Burkholderia cepecia what a "BUG"

Keren Nathan, MD and Galit Livnat, MD, CF Center, Carmel Medical Center, Haifa

14:05 - 14:20

 Aspergillus – bystander or intruder

Malena Cohen-Cymberknoh, MD, CF Center, Hadassah Medical Center, Jerusalem

14:20 – 14:35

The role of CPET in assessing lung disease in CF

Meir Mei-Zahav, MD, Graub CF Center, Schneider Children's Medical Center,

Petah Tikva

14:35 – 14:50

The long term effect of bronchdilators on cough efficiency in CF and the relation to airway responsiveness - a longitudinal study

Moshe Ashkenazi, MD, The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer

14:50– 15:30

Coffee Break and  Exhibition 

Session B: CF as a multisystem disease

Chairs: Dr. Micha Aviram, MD and Dr. Huda Georgy Mussaffi, MD

(Session conducted in Hebrew/English)

15:30 – 15:45

Fecal Calprotectin as a marker of intestinal inflammation in CF

Zeev Schnapp, MD, CF Center, Carmel Medical Center, Haifa

15:45 – 16:00

Iron deficiency and its treatment in CF

Dana Serfaty, MPH RD , Graub CF Center, Schneider Children's Medical Center, Petah Tikva and Hila Alterovits, MPH RD, CF Center, Carmel Medical Center, Haifa

16:00 – 16:15

Fertility and Pregnancy in women with CF: Management, drug safety and obstetric complications

Michal Shteinberg, MD, PhD, CF Center, Carmel Medical Center, Haifa

16:15 – 16:30

Long term effect of orkambi  treatment on ΔF508 homozygous patients in Israel

Dario Prais, MD,  Graub CF Center, Schneider Children's Medical Center, Petah Tikva

16:30 – 16: 45

Kalydeco and CFTR mutations associated with Residual Function: the Israeli experience

Alex  Gileles – Hillel, MD,  CF Center, Hadassah Medical Center, Jerusalem

16:45 – 17:00

Current and long term safety data with innovative treatments for CF

Hannah Blau, MBBS, Graub CF Center, Schneider Children's Medical Center,

Petah Tikva

17:00 – 17:30

Adherence - Why my patients don’t listen to me

Peter J. Mogayzel, MD, Johns Hopkins Cystic Fibrosis Center, Baltimore, Maryland